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Abstract—The mechanisms that lead to mitochondrial damage under oxidative stress conditions were examined in
synaptosomes treated with ascorbate/iron. A loss of membrane integrity, evaluated by electron microscopy and by LDH
leakage, was observed in peroxidized synaptosomes and it was prevented by pre-incubation with vitamin E (150 mM)
and idebenone (50 mM). ATP levels decreased, in synaptosomes exposed to ascorbate/iron, as compared to controls.
NADH-ubiquinone oxidoreductase (Cx I) and cytochrome c oxidase (Cx IV) activities were unchanged after ascorbate/
iron treatment, whereas succinate-ubiquinone oxidoreductase (Cx II), ubiquinol cytochrome c reductase (Cx III) and
ATP-synthase (Cx V) activities were reduced by 55%, 40%, and 55%, respectively. The decrease of complex II and
ATP-synthase activities was prevented by reduced glutathione (GSH), whereas the other antioxidants tested (vitamin E
and idebenone) were ineffective. However, vitamin E, idebenone and GSH prevented the reduction of complex III
activity observed in synaptosomes treated with ascorbate/iron. GSH protective effect suggests that the oxidation of
protein SH-groups is involved in the inhibition of complexes II, III and V activity, whereas vitamin E and idebenone
protection suggests that membrane lipid peroxidation is also involved in the reduction of complex III activity. These
results may indicate that the inhibition of the mitochondrial respiratory chain enzymatic complexes, that are differen-
tially affected by oxidative stress, can be recovered by specific antioxidants. © 1998 Elsevier Science Inc.
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INTRODUCTION
Oxidative stress has been implicated in many patholog-
ical situations occurring in the Central Nervous System
(CNS), namely in neurodegenerative disorders, such as
Parkinson’s and Alzheimer’s diseases, and in the physi-
ological process of aging [1,2]. Nervous tissue is very
susceptible to oxidative stress, due to its high rate of
oxygen consumption, relatively low levels of antioxidant
defenses, and a high content of polyunsaturated fatty
acids and transition metal ions [3,4]. The increased for-
mation and release of reactive oxygen species (ROS),
induces structural and functional alterations of cellular
membranes [5]. These alterations are promoted by the
attack of free radicals to membrane polyunsaturated fatty
acids [6], proteins and DNA [2].
The cells contain a number of antioxidant defenses
that protect them from oxidative insults. These defenses
can be provided by specific enzymes, like superoxide
dismutase, glutathione peroxidase and catalase and also
by non-enzymatic compounds like vitamin E and gluta-
thione [1,6,7]. Mitochondria is the major source of ROS
[8], because ubiquinones and cytochrome b family (in
complex III) do not retain the partially reduced oxygen
intermediates in their active sites, as occurs with cyto-
chrome aa3, resulting in the electrons transfer directly to
oxygen with the formation of the superoxide radical [9].
During oxidative stress free radical production is in-
creased, leading to an alteration of the chemical and
physical state of the mitochondrial inner membrane
(MIM), where ubiquinone redox cycling operates [10].
The alteration of the phospholipid structure in the mito-
chondrial inner membrane compromises the functional-
ity of the electron transport chain (ETC), leading to
energy failure and eventually to cell death [11].
In the present study we analyzed the effect of oxida-
tive stress, induced by ascorbate/iron, on the activity of
the mitochondrial respiratory chain complexes in rat
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brain cortex synaptosomes. The viability of the synapto-
somes was analyzed by electron microscopy and LDH
leakage. Adenine nucleotide levels were evaluated in
order to establish the functionality of mitochondrial
ETC. In addition, the effects of vitamin E, idebenone and
reduced glutathione (GSH), in preventing the decrease of
the activity of mitochondrial respiratory chain com-
plexes, induced by oxidative stress, were analyzed. The
predominant involvement of lipid peroxidation and pro-
tein oxidation in the impairment of mitochondrial respi-
ratory chain activity was also evaluated.
MATERIALS AND METHODS
Animals, chemicals and reagents
The animals used in these studies were male Wistar
rats, 1.5 months old, supplied with normal laboratory
diet. All chemicals used were of analytical grade and
were obtained from Sigma, (USA). The following com-
pounds were obtained as generous gifts: CoQ1 and CoQ2
from Eisai Chemical Company, Tokyo, Japan, and Ide-
benone from Seber, Portugal.
Isolation of synaptosomes
Synaptosomes were prepared from rat brain cortex
homogenates, according to the method of Hajo´s [12],
slightly modified [13]. The synaptosomal pellets were
washed and resuspended in buffered sucrose medium at
4°C. Synaptosomal protein concentrations were mea-
sured by the Biuret method [14], using bovine serum
albumin as standard.
Induction and quantification of lipid peroxidation
Ascorbic acid and Fe21 were used to induce lipid
peroxidation [15] and the extent of the peroxidative
process was determined by the thiobarbituric acid test
(TBA) [16]. Synaptosomes (1 mg/ml of protein, final
concentration) were incubated at 30°C for 15 min, in
Na1-medium containing: 132 mM NaCl, 1 mM KCl, 1
mM MgCl2, 10 mM glucose, 10 mM Hepes-Tris, pH 7.4,
with 0.8 mM ascorbic acid and 2.5 mM Fe21, in the
presence or in the absence of antioxidants. Controls were
incubated at 30°C during the same period of time, in the
absence of ascorbic acid and ferrous sulfate, with or
without antioxidants.
The oxidative protectors, vitamin E (150 mM) and
idebenone (50 mM), were preincubated for 20 or 15 min,
respectively, whereas glutathione (250 mM) was added
simultaneously with the oxidant agents, ascorbate and
iron. Stock solutions of vitamin E and idebenone were
prepared in 100% ethanol. The final concentration of
ethanol (0.8% v/v) present in the experimental assay was
shown to have no effect by itself. After induction of lipid
peroxidation, synaptosomes were centrifuged and the
pellets were washed and resuspended in Na1 medium.
Control and peroxidized synaptosomes were frozen in
liquid nitrogen and stored at 280°C for further enzy-
matic analyzes.
LDH measurements
Synaptosomes plasma membrane integrity was anal-
ysed by monitoring the activity of the cytoplasmic en-
zyme LDH in the extracellular incubation medium. LDH
activity was measured spectrophotometrically, according
to the method of Bergmeyer and Brent [17], by following
the rate of conversion of NADH to NAD1, at 340 nm.
LDH leakage was expressed as a percentage of total
LDH activity, which corresponds to the activity deter-
mined in the supernatant plus that determined after re-
suspension of synaptosomal pellets in a hypotonic solu-
tion containing 15 mM Tris, pH 7.4.
Electron microscopy
Synaptosomal crude fraction was fixed by the addition
of Karnousky reagent (phosphate-buffered 0.1 mol/L, pH
7.2 and 2.5% glutaraldehyde solution), during 1 hour at
4°C. The fixed pellets were then washed with 100 mM
sodium cacodylate buffer (pH 7.2). Pellets were included
in 1% Agar and then dehydrated in grade ethanol and
embedded in Spur. The ultrathin sections were cut with
an LKB ultra-microtome ULTROTOME III, then con-
trasted with uranyl acetate and with lead citrate for
transmission electron microscopy. Electron microphoto-
graphs were taken with a JEOL JEM-100 SX electron
microscope operated at 80 kV.
Analysis of adenine nucleotides
After the incubation period, 1 mg protein was ex-
tracted, in ice, with 1.2 M perchloric acid. The acid
extracts were centrifuged at 14,000 3 g for 1 min. The
resulting supernatants were then neutralized with KOH/
Tris and stored at 280°C for further analysis. Adenine
nucleotides (ATP, ADP and AMP) were assayed by
separation in a reverse-phase HPLC, as described by
Stocchi et al. [18]. The chromatographic apparatus used
was a Beckman System Gold, consisting of a 126 Binary
Pump Model and a 166 Variable UV detector, controlled
by computer. The column used was a Lichrospher 100
RP-18 (5 mm) from Merck (Germany). An isocratic
elution with 100 mM KH2PO4 buffer at pH 7.4 and 1%
methanol, was performed at a flow rat of 1.2 ml/min. The
4 S. M. CARDOSO et al.
adenine nucleotides (ATP, ADP and AMP) were de-
tected at 254 nm, for 6 min.
Citrate Synthase assay
Citrate Synthase activity was measured according to
the method of Coore et al. [19], which couples CoA to
Ellman’s reagent [5,59-dithiobis (2-nitrobenzoic acid),
DTNB]. The formation of 5-thio-2-nitrobenzoate was
monitored at 412 nm. The reaction mixture contained
100 mM Tris, pH 8.0, 200 mM acetyl-CoA, 200 mM
DTNB, 0.1% (v/v) Triton X-100, and synaptosomal sam-
ple. The assay was initiated by the addition of 100 mM
oxaloacetate at 30°C. Results were expressed as nmol/
min/mg protein.
NADH-Ubiquinone Oxidoreductase (Cx I) assay
Mitochondria complex I activity was measured using
a modification of the method of Ragan et al. [20], deter-
mining the decrease in NADH absorbance at 340 nm,
that leads to the reduction of ubiquinone (CoQ1) to
ubiquinol. The reaction was initiated by the addition of
CoQ1 (50 mM) to the reaction mixture containing 20 mM
potassium phosphate, pH 7.2, 10 mM MgCl2, 0.15 mM
NADH, 2.5 mg BSA-FFA, 1 mM KCN, and the synap-
tosomal sample, at 30°C. After 5 min, rotenone (10 mM)
was added and the reaction was registered for a further 5
min. The activity of Cx I, expressed as nmol/min/mg
protein, was determined using the rotenone sensitive
rate.
Succinate-Ubiquinone Oxidoreductase (Cx II) assay
The activity of complex II was measured using a
modified method from Hatefi and Stiggal [21]. The ac-
tivity of Cx II was measured by following the secondary
reduction of a dye (6,6-dichlorophenolindophenol,
DCPIP) by the ubiquinol formed; after the reduction of
ubiquinone (CoQ2) the disappearance of DCPIP was
monitored at 600 nm. The reaction mixture contained 50
mM potassium phosphate buffer, pH 7.4, 20 mM sodium
succinate, 0.1 mM di-K EDTA, 74 mM DCPIP, 1 mM
KCN, 10 mM rotenone and the synaptosomal sample.
The reaction, performed at 30°C, was initiated by the
addition of CoQ2 (50 mM), and TTFA (2-thenoytriflu-
oroacetone) was added 5 min later, in order to inhibit Cx
II activity. Results were expressed as nmol/min/mg pro-
tein, the activity of Cx II being determined by using the
TTFA sensitive rate.
Succinate Cytochrome C Oxidoreductase (Cx II/III)
assay
Cx II/III activity was measured according to the
method of King [22]. This assay measures the appear-
ance of reduced cytochrome c at 550 nm. The reaction
mixture contained 0.1 M potassium phosphate, pH 7.4,
0.3 mM di-K EDTA, and 0.1 mM cytochrome c. The
synaptosomal sample was pre-incubated at 30°C for 5
min with 20 mM succinate, 1 mM KCN to activate the
enzyme, and then added to the reaction mixture. The
reaction was performed at 30°C. Antimycin A (0.02
mM) was added to inhibit Cx II/III. Activity of Cx II/III,
expressed as nmol/min/mg protein, was that measured by
using the antimycin A sensitive rate.
Ubiquinol Cytochrome C Reductase (Cx III) assay
Mitochondria Cx III activity was measured according
to the method of Ragan et al. [20]. This enzyme donates
electrons from ubiquinol (UQ2H2) to cytochrome c, lead-
ing to the reduction of cytochrome c that was monitored
at 550 nm. The enzymatic reaction is of first order and
dependent on the concentration of both UQ2H2 and cy-
tochrome c. The concentrations of these compounds
were determined prior to the assay. The reaction mixture
contained 35 mM potassium phosphate, pH 7.2, 1 mM
di-K EDTA, 5 mM MgCl2, 1 mM KCN, 5 mM rotenone,
15 mM cytochrome c and the synaptosomal sample. The
reaction was initiated by addition of substrate, ubiquinol
(15 mM). The activity of Cx III was calculated by the
pseudo-first order constant K and the results were ex-
pressed as K/min/mg protein.
Cytochrome C Oxidase (Cx IV) assay
Cx IV activity was measured according to the method
of Wharton and Tzagoloff [23] by evaluating the oxida-
tion of cytochrome c as a decrease in absorbance at 550
nm. Cytochrome c was reduced with a few crystals of
ascorbate, mixed and placed into a dialysis membrane for
18–24 h against 0.01 M phosphate buffer, pH 7.0, at 4°C.
Reduced cytochrome c concentration was then deter-
mined with 0.1 M ferricyanide. The reaction mixture
contained 0.01 M potassium phosphate, pH 7.0 and 50
mM reduced cytochrome c. The reaction was initiated by
the addition of the synaptosomal sample, at 30°C. The
pseudo first order rate constant K was calculated, be-
cause the reaction is of first order with respect to cyto-
chrome c and the results were expressed as K/min/mg
protein.
Mitochondria ATP-Synthase (Cx V) assay
The enzymatic activity of ATPase in the mitochon-
drial inner membrane in synaptosomes was monitored at
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660 nm, according to the method of Taussky and Shorr
[24]. Synaptosomes (0.1 mg protein) were incubated in 1
ml of Na1 medium at 30°C, during 10 min in the
presence or absence of oligomycin, 1 mg/mg protein. The
reaction was initiated by the addition of 1 mM ATP-
Mg21 at pH 7.4, and the synaptosomes were incubated
for further 15 min at 30°C. The reaction was stopped by
the addition of ice cold 40% TCA. Protein was pelleted
by centrifugation at 3,000 3 g, during 5 min. The
absorbance in the supernatant was measured at 660 nm,
5 min after the addition of molibdate reagent. The
amount of Pi produced was determined using a phos-
phate standard curve. Results were expressed as nmol
Pi/mg protein. The difference between the activity de-
termined in the presence or in the absence of oligomycin,
corresponds to the ATP-synthase activity.
Protein oxidation determination
Protein carbonyl content was determined as described
by Levine et al. [25], with slight modifications (Cardoso
et al., personal communication). Synaptosomal pellets (1
mg) were incubated with 0.5 ml of 10 mM DNPH in 2 N
HCl (or 2 N HCl alone for the blanks), for 1 h at room
temperature. The protein hydrazone derivatives were
precipitated with 0.5 ml of 20% trichloroacetic acid, and
the precipitates were washed three times with 1 ml eth-
anol:ethylacetate (1:1). During each washing, the ho-
mogenized pellet was vortexed and left in the washing
solution for 10 min before centrifugation. The final pellet
was resuspended and incubated in 6 M guanidine HCl,
for 15 min at 37°C. The carbonyl content was determined
spectrophotometrically at 360 nm on the basis of molar
absorbance coefficient of 22,000 M21 cm21.
Data analysis
Data were expressed as means 6SE of the indicated
number of determinations, from at least three indepen-
dent experiments. Statistical significance analysis was
determined using the two-tailed Student’s t-test (a p
value of ,.05 was considered significant).
RESULTS
Influence of ascorbate/iron on lipid peroxidation
Synaptosomes exposed to 0.8 mM ascorbate/2.5 mM
iron, showed an extent of lipid peroxidation of 18.03 6
0.88 nmol TBARS/mg protein, significantly different
from that determined in control synaptosomes, incubated
in the absence of the oxidant pair (2.62 6 0.29 nmol
TBARS/mg protein) (Table 1). When synaptosomes
were preincubated with 150 mM vitamin E, for 20 min,
TBARS production determined after incubation with
ascorbate/iron was 10.57 6 1.55 nmol TBARS/mg pro-
tein, this value being statistically higher than that of
controls pre-incubated with vitamin E (2.84 6 0.16 nmol
TARS/mg protein), but lower than that of peroxidized
synaptosomes, incubated only in the presence of ascor-
bate/iron (18.03 6 0.88 nmol TBARS/mg of protein).
When synaptosomes were pre-incubated with 50 mM
idebenone, in the absence of ascorbate/iron, the extent of
lipid peroxidation was 2.76 6 0.26 nmol TBARS/mg
protein. In the presence of ascorbate/iron, after pre-incu-
bation with idebenone, the level of TBARS was similar
to that observed in the absence of the oxidant pair,
2.74 6 0.32 nmol mg protein, a value that is statistically
different from that determined in peroxidized synapto-
somes (18.03 6 0.88 nmol TBARS/mg of protein).
Glutathione did not completely protect synaptosomes
from lipid peroxidation. The extent of lipid peroxidation
increased by 1.5-fold in synaptosomes incubated only
with 250 mM GSH, (4.64 6 0.1 nmol TBARS/mg pro-
tein). However, when synaptosomes were peroxidized in
the presence of GSH, a significant decrease of the extent
of lipid peroxidation was observed as compared with
synaptosomes oxidized in the absence of GSH (12.51 6
1.18 and 18.03 6 0.88 nmol TBARS/mg protein, respec-
tively).
Synaptosomes viability upon lipid peroxidation
Synaptosomes viability was measured by the LDH
leakage to the extracellular medium. A significant in-
crease in LDH leakage, of about 3-fold, was observed in
peroxidized synaptosomes (38.88 6 1.91%) as compared
to control synaptosomes (12.92 6 0.90%) (Fig. 1). The
Table 1. Effect of Ascorbate/Iron on the Production of TBARS
Levels of TBARS
(nmol/mg of protein)
Control 2.62 6 0.29
Ascorbate/iron 18.03 6 0.88c
Control 1 vit E 2.84 6 0.16
Ascorbate/iron 1 vit E 10.57 6 1.55b,e
Control 1 IDB 2.76 6 0.26
Ascorbate/iron 1 IDB 2.74 6 0.317f
Control 1 GSH 4.64 6 0.1h
Ascorbate/iron 1 GSH 12.51 6 1.18b,e
Synaptosomes were submitted for 15 min to ascorbate (0.8 mM)/iron
(2.5 mM), and pre-incubated with or without antioxidants, like vitamin
E (vit E, 150 mM), idebenone (IDB, 50 mM), and GSH (250 mM). The
extent of lipid peroxidation, measured by TBARS production, was
determined in synaptosomal pellets as described in Materials and
Methods. Data are expressed as mean 6 SEM for 10–20 independent
preparations. aSignificantly different when compared to the appropriate
control (bp , .01, cp , .001). dSignificantly different when compared
to peroxidized synaptosomes (ep , .01, fp , .001). gSignificantly
different when compared to control synaptosomes (hp , .01).
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LDH leakage in controls pre-incubated with vitamin E
and idebenone was similar to that measured in controls in
the absence of antioxidants (10.74 6 0.80% and 13.67 6
0.71%, respectively). Vitamin E and idebenone protected
the LDH release from oxidized synaptosomes (10.96 6
2.60% and 12.33 6 1.45%, respectively). When synap-
tosomes were incubated with GSH and ascorbate/iron, no
significant decrease in LDH leakage was observed
(44.96 6 2.50%), as compared with that determined in
synaptosomes treated with ascorbate/iron in the absence
of GSH. However, the increase in the LDH leakage
observed after an ascorbate/iron treatment is reduced in
the presence of GSH because when synaptosomes were
incubated in the presence of GSH alone, an increase in
LDH leakage occurred, as compared to controls
(31.50 6 5.20% and 13.67 6 0.71%, respectively). The
morphology of the washed crude synaptosomal fraction
was also analyzed by electron microscopy. In synapto-
somes incubated in the absence of ascorbate/iron at
30°C, plasma membrane integrity was maintained (Fig.
2A). When synaptosomes were treated with ascorbate/
iron, plasma membrane discontinuities were observed as
compared to control synaptosomes (Fig. 2B).
Respiratory chain enzyme activities upon oxidative
stress
Table 2 shows the activities of mitochondria respira-
tory chain complexes, expressed relatively to citrate syn-
thase activity to compensate any variation in mitochon-
dria enrichment, and also the actual values of the
enzymatic activities. The citrate synthase activity can be
used for correcting mitochondrial enzyme activities, be-
cause it did not change with ascorbate/iron treatment
(data not shown). As can be observed in Table 2 there
was no significant difference in NADH-Ubiquinone Ox-
idoreductase (Cx I) and in Cytochrome C Oxidase (Cx
IV) activities, when synaptosomes were incubated with
ascorbate/iron, but Succinate-Ubiquinone Oxidoreduc-
tase (Cx II) activity decreased significantly in peroxi-
dized synaptosomes (0.036 6 0.005), as compared with
control synaptosomes (0.071 6 0.004). The incubation
with ascorbate/iron for 15 min inhibited Succinate Cy-
tochrome C Oxidoreductase (Cx II/III) activity for about
2.5-fold (from 0.156 6 0.007 in controls to 0.063 6
0.004 in peroxidized synaptosomes). Ubiquinol Cyto-
chrome C Reductase (Cx III) activity decreased for about
1.07-fold in oxidized synaptosomes (0.064 6 0.006) as
compared with controls (0.106 6 0.009). ATP-Synthase
(Cx V) activity was also inhibited in synaptosomes
treated with ascorbate/iron by about 1.87-fold (from
5.62 6 0.46 in controls to 3.01 6 0.27 in peroxidized
synaptosomes). This reduction of mitochondrial respira-
Fig. 1. Effect of oxidative stress on the LDH-leakage in synaptosomes
exposed to 0.8 mM ascorbate and 2.5 mM iron, for 15 min, with or
without 150 mM vitamin E (vit E), 50 mM idebenone (IDB) or 250 mM
GSH. LDH activity was determined in synaptosomal preparations as
described in Materials and Methods. Data are expressed as the mean 6
SEM for 4 independent preparations. *Significantly different when
compared to the appropriate control (*p , .05, ***p , .001).
1Significantly different when compared to synaptosomes treated with
ascorbate/iron (111p , .001).
Fig. 2. Electron micrograph of subcellular particles constituting the
washed crude synaptosomal pellet. (A) Control synaptosomes. (B)
Synaptosomes treated with 0.8 mM ascorbate and 2.5 mM iron, for 15
min, at 30°C. sy (synaptosomes); mt (mitochondria in nerve endings);
363,000.
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tory chain complexes activities was statistically signifi-
cant for the enzymatic complexes analysed.
Effect of oxidative stress on adenine nucleotides levels
The ATP levels in synaptosomes submitted to oxida-
tive stress, decreased for about 1.8-fold (2.63 6 0.07
nmol/mg of protein in controls; 1.44 6 0.06 nmol/mg of
protein in peroxidized synaptosomes) (Fig. 3), while the
levels of ADP and AMP were not significantly affected
(data not shown).
The ATP levels in controls pre-incubated with vita-
min E, idebenone, GSH, and with all the antioxidants put
together, were similar to those measured in controls
(1.97 6 0.0.38, 2.05 6 0.47, 2.37 6 0.32 and 3.19 6
0.41 nmol/mg protein, respectively) (Fig. 3). In the pres-
ence of idebenone, GSH and a mixture of all the anti-
oxidants, the ATP levels in oxidized synaptosomes were
maintained (2.44 6 0.31, 2.21 6 0.24 and 2.71 6 0.19
nmol/mg protein, respectively). Vitamin E was not effi-
cient on the maintenance of ATP levels in peroxidized
synaptosomes (1.79 6 0.72 nmol/mg protein) (Fig. 3).
Effects of free radical scavengers on Complex II, III,
and V activities
When synaptosomes were pre-incubated with 150 mM
vitamin E and 50 mM idebenone, the inhibition of com-
plex II activity, measured after ascorbate/iron treatment,
remained similar to that observed in the absence of the
antioxidants (40% and 50%, respectively), the difference
in the value being not statistically significant. In the
presence of reduced glutathione (GSH), Complex II ac-
tivity was almost completely preserved (91.92%) from
ascorbate/iron inhibitory effect (Fig. 4A).
When the free radical scavengers vitamin E and ide-
benone were pre-incubated with synaptosomes, or GSH
was added simultaneously with ascorbate/iron, the inhi-
bition of complex III activity was prevented (Fig. 4B).
The presence of the free radical scavengers, vitamin E
and idebenone, had no protective effect on ATP-synthase
activity, an inhibition of 33.68% and 38.13% being ob-
served, respectively. GSH, when incubated simulta-
neously with ascorbate/iron, almost completely protected
ATP-synthase activity (99.82%) (Fig. 4C).
The effect of oxidative stress and free radical
scavengers on the formation of Carbonyl Groups
Synaptosomes submitted to 0.8 mM ascorbate/2.5 mM
iron shown an increased formation of carbonyl groups,
for about 3-fold, as compared to controls (1.56 6 0.07
and 0.51 6 0.06 nmol/mg protein, respectively) (Fig. 5).
Fig. 3. Effect of oxidative stress and antioxidants on adenine nucleo-
tides levels in synaptosomes exposed to 0.8 mM ascorbate and 2.5 mM
iron, for 15 min, with or without 150 mM vitamin E (vit E), 50 mM
idebenone (IDB) or 250 mM GSH. ATP levels were determined in
synaptosomal preparations as described in Materials and Methods. Data
are expressed as the mean 6 SEM for 3–5 independent preparations.
*Significantly different when compared to the appropriate control
(***p , .001). 1Significantly different when compared to synapto-
somes treated with ascorbate/iron (11p , .01, 111p , .001).
Table 2. Mitochondrial Respiratory Chain Complexes Activities in Synaptosomal Mitochondria
MRC/Citrate Synthase activity MRC activity
Control Peroxidized Control Peroxidized
Complex I 0.065 6 0.0046 0.059 6 0.0041 31.61 6 2.23 28.69 6 1.99
Complex II 0.071 6 0.0044 0.036 6 0.0055b 34.53 6 2.14 17.51 6 2.67b
Complex II/III 0.156 6 0.0071 0.063 6 0.0048c 75.86 6 3.45 30.64 6 2.33c
Complex III 0.106 6 0.0097 0.064 6 0.0065b 51.55 6 4.72 31.12 6 3.16b
Complex IV 0.899 6 0.06 0.868 6 0.077 437.17 6 29.18 422.09 6 37.44
Complex V 5.62 6 0.468 3.01 6 0.278c 2732.89 6 227.58 1463.70 6 135.19c
Synaptosomes were exposed to ascorbate (0.8 mM)/iron (2.5 mM) for 15 min, at 30°C. Enzymatic activities
were determined as described in Materials and Methods and expressed in terms of nmol/min/mg protein for
complexes I, II, V; and in terms of K/min/mg protein for complexes III and IV. Results are expressed as the
mean 6 SEM for 4–6 independent synaptosomal pellets. aSignificantly different when compared to control
synaptosomes (bp , .01, cp , .001).
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The carbonyl content, in oxidized synaptosomes pre-
incubated with vitamin E, decreased in comparison to
synaptosomes treated with ascorbate/iron (1.19 6 0.13,
1.56 6 0.07 nmol/mg protein, respectively), but vitamin
E did not rescue the carbonyl content to control values
(0.56 6 0.04 nmol/mg protein). Idebenone prevented the
formation of carbonyl groups in peroxidized synapto-
somes (0.82 6 0.12 nmol/mg protein). When synapto-
somes were incubated in the presence of GSH alone, a
small increase in carbonyl content was observed as com-
pared to controls, this increase being statistically not
significant (0.90 6 0.15 and 0.51 6 0.06 nmol/mg pro-
tein, respectively). However, a decrease in carbonyl
groups occurred in oxidized synaptosomes incubated
with glutathione, in comparison to synaptosomes treated
only with the oxidant agents (1.14 6 0.13 and 1.56 6
0.07 nmol/mg protein, respectively).
DISCUSSION
The objective of this work was to define the mecha-
nisms whereby oxidative stress leads to mitochondrial
respiratory chain injury. For this purpose, we investi-
gated the effect of ascorbate/iron mediated oxidative
stress on the activity of mitochondrial respiratory chain
enzymatic complexes in brain cortex synaptosomes. Our
results show that ascorbate/iron gives rise to a marked
inhibition of complex II, complex III, and complex V
activities that can be prevented by the antioxidants vita-
min E, idebenone, and GSH.
Ascorbate/iron has been shown to give rise to the
highly reactive hydroxyl radical by the iron-catalyzed
Haber–Weiss reaction [26,27]. The superoxide anion
radical appears to be the first oxygen reduction product
generated under both physiological and pathological
conditions [8]. Subsequent dismutation of superoxide
radical generates hydrogen peroxide and the reaction of
H2O2 with superoxide, in the metal-catalyzed Haber–
Weiss reaction can result in the production of the hy-
droxyl radical [8].
Fig. 4. Effect of oxidative stress and antioxidants on the activity of
mitochondrial respiratory chain complexes in synaptosomes exposed to
0.8 mM ascorbate and 2.5 mM iron, for 15 min, with or without 150
mM vitamin E (vit E), 50 mM idebenone (IDB) or 250 mM GSH. (A)
The activity of Succinate-Ubiquinone Oxidoreductase (Cx II); (B) The
activity of Ubiquinol Cytochrome c Reductase (Cx III); (C) The activ-
ity of ATP-synthase(Cx V). Mitochondrial respiratory chain complexes
activity was determined in synaptosomal preparations as described in
Materials and Methods. Data are expressed as the mean 6 SEM for
4–7 independent preparations. *Significantly different when compared
to the appropriate control (**p , .01, ***p , .001). 1Significantly
different when compared to synaptosomes treated with ascorbate/iron
(1p , .05, 11p , .01, 111p , .001).
Fig. 5. Effect of oxidative stress and antioxidants on carbonyl content
in synaptosomes exposed to 0.8 mM ascorbate and 2.5 mM iron, for 15
min, with or without 150 mM vitamin E (vit E), 50 mM idebenone
(IDB) or 250 mM GSH. Carbonyl groups were determined in synap-
tosomal preparations as described in Materials and Methods. Data are
expressed as the mean 6 SEM for 5 independent preparations. *Sig-
nificantly different when compared to the appropriate control (**p ,
.01, ***p , .001). 1Significantly different when compared to per-
oxidized synaptosomes (1p , .05, 11p , .01, 111p , .001).
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In this study, the antioxidants vitamin E, idebenone
and GSH were tested, in order to gain a better insight into
the mechanisms by which free radicals, formed after
treatment with ascorbate/iron, induce lipid and protein
alterations. Vitamin E is a lipophilic antioxidant that acts
as a free radical scavenger, being able to donate hydro-
gen to radicals, usually peroxyl and alkoxyl radicals, thus
preventing the propagation of lipid peroxidation [26].
Because it is localized into the hydrocarbon core of the
phospholipid bilayer, it protects polyunsaturated fatty
acids and thiol groups of membrane proteins, keeping the
integrity and function of biomembranes [28]. Idebenone
is also a lipophilic antioxidant, that besides acting as a
free radical scavenger it can prevent free radical forma-
tion being an electron carrier, like ubiquinone [29]. The
antioxidant GSH is involved in the inactivation of H2O2,
being the substrate of glutathione peroxidase, it also acts
as a free radical scavenger by giving H1 to superoxide
and hydroxyl radical [30] and prevents s-thiolation of
proteins.
When synaptosomes are treated with ascorbate/iron,
lipid peroxidation occurs (Table 1), as measured by the
formation of free malonaldehyde (MDA), one of the last
products formed during the peroxidative process [31].
Evidence exists that one of the major physiological tar-
gets of free radicals is the unsaturated fatty acyl side
chains of phospholipids and their degradation leads to
alterations of membrane fluidity and lipid composition
[5,32,33]. An increase in LDH leakage was observed
(Fig. 1) in synaptosomes treated with ascorbate/iron,
suggesting that plasma membrane is functionally and
structurally altered after membrane lipid peroxidation, as
previously shown in our laboratory [34]. Vitamin E and
idebenone were able to prevent the LDH leakage, by
acting in the prevention of plasma membrane lipid per-
oxidation (Table 1). GSH also prevented the LDH leak-
age to a lesser extent. Besides the alteration in synapto-
somal plasma membrane structure, mitochondria
structural integrity is preserved, as can be observed by
electron microscopy (Fig. 2).
There is considerable evidence that oxidative stress
induces alterations not only in membrane lipids, but also
in proteins and DNA [3,9]. Recently, Goldstein et al.
[35] suggested that •OH radicals damage peptides in the
presence of transition metal ions. After incubation of
cortical synaptosomes with ascorbate/iron for 15 min, a
significant decrease in the activity of the mitochondrial
respiratory chain complexes II, III and V was observed
(Table 2). In contrast, the activity of complex I and IV
was not significantly affected upon oxidative stress in-
duced by ascorbate and iron (Table 2). ATP levels,
determined under these conditions, were also signifi-
cantly decreased (Fig. 3), but ADP and AMP levels were
maintained (data not shown). However, when synapto-
somes were incubated in the presence of idebenone,
reduced glutathione (GSH), or in the presence of the
three antioxidants (vitamin E, idebenone and GSH), ATP
levels were similar to those of controls (Fig. 3). GSH
prevented the drop in ATP levels but did not completely
prevent LDH leakage (Fig. 1). Previous studies in our
laboratory showed that the membrane potential of syn-
aptosomes, treated with ascorbate/iron during 15 min,
was similar to that of controls, suggesting that, under
these conditions, synaptosomal plasma membrane
Na1/K1 gradients are not significantly altered [36,37].
Oxidative stress has been shown to affect the activity
of key mitochondrial enzymes, subsequently leading to a
decline in ATP production [25,38,39]. Our results sug-
gest that the maintenance of ATP levels is probably due
to a protective effect of antioxidants on mitochondrial
respiratory chain complexes, since vitamin E and ide-
benone, as well as the reducing agent GSH, were able to
prevent the inhibition of complex III activity, while only
GSH protected complexes II and V from the inhibitory
effect induced by oxidative stress.
After the induction of oxidative stress with ascorbate/
iron, Reinheckel [40] showed a decrease in complex I
activity with a posterior inhibition of complex III activity
and they proved that the decline of complex III activity,
during the initial phase of lipid peroxidation, could be
correlated to structural breakdown of the complex pro-
teins. Andree´ et al. [41] demonstrated that the depletion
of the ubiquinone pool played an important role in the
inhibition of the electron transfer chain (ETC), when
lipid peroxidation occurred. They demonstrated that the
preferential targets leading to the inhibition of the respi-
ratory chain complexes I and II activities, were the
partial reactions that involve ubiquinones. It has been
shown that, under lipid peroxidation conditions superox-
ide radical, O2•2, is released, because ubiquinones and
cytochrome b family loose the capacity to retain the
partially reduced oxygen intermediates, until oxygen is
completely reduced to water [1,42]. The reaction of
superoxide anion with Fe21 can generate hydroxyl rad-
icals that increase the hydrophilic properties of mito-
chondrial inner membrane lipids favoring the auto-oxi-
dation of ubisemiquinones, leading also to an increased
release of electrons from the normal chain sequence [43].
On the other hand, the ubisemiquinone formed can func-
tion as a reductant for hydrogen peroxide, leading to the
formation of hydroxyl radicals [44]. However, this
mechanism involving lipid peroxidation can not explain
per se the decrease of complex II activity in synapto-
somes treated with ascorbate/iron, because vitamin E and
idebenone, that are lipid-soluble antioxidants inhibited
lipid peroxidation without protecting complex II enzy-
matic activity. Our results show an inhibition of complex
II activity, probably due to a direct damage on the
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complex proteins, because this inhibition is prevented by
reduced glutathione but not by vitamin E or idebenone
(Fig. 4A). GSH, acting as a free radical scavenger, can
help to regulate the thiol disulfide concentration of com-
plex II subunits, as has been demonstrated for a number
of glycolytic enzymes [9] and Ca21-ATPases [45]. Un-
der severe oxidative stress reduced glutathione can be
used as an antioxidant defense, and oxidized glutathione
concentration increases. We found that in synaptosomes
treated with ascorbate/iron, the GSH/GSSG ratio de-
creases (data not shown), suggesting an accumulation of
GSSG and a possible oxidation of protein thiol groups,
resulting in a possible alteration of mitochondria mem-
branes and enzymes activity [46].
It has been reported that oxidative stress, either in-
duced by oxidizing agents or occurring during aging,
inhibits mitochondrial respiratory chain complexes
(complex I and/or complex IV) [47–51]. However, the
unchanged activities of complexes II, III and V, under
peroxidative conditions, are far from being clarified.
Studies with MPTP [48,50] revealed an inhibition of
complex I activity, due to a free radical damage. The
binding of MPP1 to a specific site in complex I has been
shown to induce ATP depletion and, as a consequence,
leads to an impairment of GSH synthesis and GSH
depletion. However, Gerlach et al. [52] showed that
mitochondrial respiratory chain enzymes were not af-
fected after treatment with MPTP, concluding that there
was no evidence that the damage of complex I was the
cause of the MPTP-toxicity. Bowling et al. [47] exam-
ined the activities of complex I, II/III, IV and V in aged
brains, finding an age-related decline in complexes I and
IV activities. These authors proposed that the inhibition
of mitochondrial respiratory chain enzymes was due to a
damage of mitochondrial DNA, that encodes for some of
the complex I and IV subunits. Although complex III and
V are also partially encoded by mitochondrial DNA [49],
their activity has not been shown to be affected by age.
More recently, Bolan˜os et al. [53] showed that com-
plexes I, II/III and IV activities decreased in neurons
exposed to the NO• donor, SNAP. This effect seems to be
likely due to peroxynitrite, formed through the reaction
of •NO with the superoxide anion. It has been reported
that peroxynitrite can react with intracellular GSH, giv-
ing rise to cellular depletion of the antioxidant and mi-
tochondria damage [53,54].
We also demonstrate a decrease in complex III activ-
ity (Fig. 4B), probably related to the production of su-
peroxide radicals at the level of cytochrome b popula-
tion, which has been shown to promote mitochondrial
membrane alterations through the dismutase reaction in
which hydrogen peroxide is formed. This effect is likely
to be related to a direct damage of a hydrophobic com-
ponent of the enzyme, since the decrease of complex III
activity was prevented by the free radical scavengers,
vitamin E and idebenone (Fig. 4B). Vitamin E is one of
the major lipid-soluble chain-breaking antioxidants in
biological systems [26] that incorporate into the plasma
membrane. It acts by interfering with the propagation of
lipid peroxidation chain reaction [55], by scavenging
lipid peroxyl and alkoxyl radicals [56]. Idebenone is a
structural analog of ubiquinone [29], which has been
suggested to act as an electron carrier, like ubiquinone
and also as a free radical scavenger. Fry and Green [57]
showed that the catalytic activity of complexes I and III
of the mitochondrial respiratory chain needs a stable
lipid environment. Cardiolipin is a negatively charged
phospholipid required for the correct interaction of cy-
tochrome c with Cytochrome Oxidase which can be
decreased in the mitochondrial inner membrane after
induction of oxidative stress [58]. However, under our
experimental conditions, the peroxidation of cardiolipine
does not seem to be involved in the inhibitory effect
observed on complex III activity, since complex I and IV
activities were unchanged, under the same conditions.
The decrease of ATP-synthase activity, after incuba-
tion with ascorbate/iron, was prevented only by GSH
(Fig. 4C), indicating that this inhibition probably results
from a direct attack of ROS on the complex proteins.
Under these conditions, mitochondrial respiratory chain
complexes proteins are oxidized, as is demonstrated by
the increase in carbonyl groups formation (Fig. 5). These
results are in agreement with other studies in which is
predicted that protein oxidation can be acutely induced
by the addition of Fe21 [59]. When synaptosomes were
pre-incubated with vitamin E, idebenone and GSH the
increase in carbonyl groups levels was not observed,
showing that membrane proteins are protected from free
radicals attack as long as antioxidants do not decline. Our
results suggest that the inhibition of mitochondrial activ-
ity mediated by oxidative stress can be related to the
deficient regeneration of endogenous antioxidants,
namely GSH that depends on the supply of hydrogen
from respiratory substrates [50].
In conclusion, mitochondrial respiratory chain enzy-
matic complexes activity is differentially affected by
oxidative stress, complex I and IV being the less vulner-
able. The protection of complexes II, III and V activities,
by free radical scavengers, suggests that the irreversible
inhibition of these complexes, induced by oxidative
stress, is mediated by free radical damage to lipids, but
protein damage is also involved, as demonstrated by the
GSH protective effect. This inhibition could lead to the
generation of ROS by the mitochondria, thus enhancing
the damaging events initiated by ascorbate/iron.
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